// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Natural History of Tricuspid Annulus and Right Atrial Remodeling in Permanent Atrial Fibrillation

Michael Tsang - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Disruption of TRAF2-TAK1-IKKB Signaling Triggers Mitochondrial Perturbations and Necrotic Cell Death in Doxorubicin Cardiotoxicity

Rimpy Dhingra - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiotoxicity

Doxorubicin

Maladaptive Autophagy and Necrotic Death of Ventricular Myocytes Induced by p53 is Contingent Upon Mitochondrial Death Gene Bnip3

Yan Wang - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Angiotensin II

Best Method for Right Atrial Volume Assessment by Two-Dimensional Echocardiography: Validation With Magnetic Resonance Imaging

Darra Murphy - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implication of DNA Damage Signaling and Epigenetic Readers in Metabolic Disorder Observed in Vascular Wall of Ischemic Patients

Sarah Henry - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metabolic syndrome

Veliparib

Long-Term Prognostic Value of and Serial Changes in Plasma N-terminal Pro B-type Natriuretic Peptide in Patients Undergoing Transcatheter Aortic Valve Implantation

Luis Nombela-Franco - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mitral valve regurgitation

N/A

Remodeling of Mitral Annulus and Left Atrium in Permanent Atrial Fibrillation: Relationship to Severity of Mitral Regurgitation

Christina Luong - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Cardiac Rehabilitation Program Adherence among Women Following Referral to Different Program Models: A Randomized Controlled Trial

Heather M Arthur - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Patient Outcomes and Quality of Life 15 years or more after the Ross Operation in Adults

Ryo Torii - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Impact of Body Mass Index on Clinical Outcomes in Complex Adult Congenital Heart Disease

Ines Uribe Morales - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Ventricular Functional Response During Exercise in Patients After Fontan

Luc Mertens - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Univentricular Heart

N/A

Biomechanical Properties of Patient-specific Aortas and Pulmonary Arteries According to Aortic Valve Phenotype: Relevance to the Ross Procedure

Evan Wener - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Closing the Cardiac Intensive Care Unit: Cost-Savings Associated with a Closed versus Open Model of Critical Care Delivery

Arun K Das - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Favorable Association Between a Mediterranean Dietary Pattern and Cardiovascular Risk Factors in Patients with Stable Coronary Heart Disease in the STABILITY Study

Lars Wallentin - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Darapladib

Management and Outcomes of Acute Type B Dissection in IRAD Treated with Open Surgery, Endovascular Flap Fenestration or TEVAR

Peter Levanovich - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Global Longitudinal Strain in Different Right Ventricular Walls Using Alternate Right Ventricular Apical Views: Validation and Establishment of Normal Values in Children

Bruce Landeck - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Infective Endocarditis Following Transcatheter Valve Implantation: A Systematic Review

Henrique B Ribeiro - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Infective endocarditis

N/A

Impact of Dyspnea: From Validity Indices to the Clinical Utility of the French-canadian Version of the Modified Dyspnea Index

Maria-Cecilia Gallani - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary arterial hypertension

N/A

The Evolution of Cardiac Output and Cerebral Blood Flow in the Perinatal Transition in Hypoplastic Left Heart Syndrome: a Longitudinal Study

Akiko Hirose - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Clinical Characteristics and Outcomes of Patients With and Without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial

Lilin She - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Copyright © 2026. QuantiNova All rights reserved